Recruiting EARLY_PHASE1 Posttraumatic Stress Symptoms

New treatment option for Posttraumatic Stress Symptoms

Official title FLOAT for Healthcare PTSS

ClinicalTrials.gov ID: NCT07710417

What this study is testing

What it's testing
This early-stage pilot trial aims to examine the feasibility, tolerability, and safety of Floatation-REST, or Reduced Environmental Stimulation Therapy via floatation in frontline healthcare workers, first responders, and emergency medical personnel who experience post-traumatic stress symptoms.
  • Phase 1: an early, usually small safety study
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 64

You may be able to join if

  • Work-related post-traumatic stress dysfunction as measured by either of the following inclusion pathways: (A) PTSS Pathway: PCL-5 greater than or...
  • First responder or other emergency medical personnel
  • Ability to read, speak and understand English
  • Capable of providing consent

You likely can't join if

  • History of neurological conditions
  • Skin conditions or open wounds
  • DSM-5 diagnosis of psychotic spectrum disorders, obsessive-compulsive disorder, bipolar disorder, severe substance use disorder, or eating disorder
  • Inability to lay comfortably in a shallow pool of water
  • Failure to adhere to "pre-float checklist"
  • Breathalyzer test positive for alcohol or a drug-positive urine test
See the full eligibility criteria
Who can join
  • Work-related post-traumatic stress dysfunction as measured by either of the following inclusion pathways: (A) PTSS Pathway: PCL-5 greater than or equal to 20, OR meets criteria for full or partial PTSD on the MINI...
  • First responder or other emergency medical personnel
  • Ability to read, speak and understand English
  • Capable of providing consent
What rules you out
  • History of neurological conditions
  • Skin conditions or open wounds
  • DSM-5 diagnosis of psychotic spectrum disorders, obsessive-compulsive disorder, bipolar disorder, severe substance use disorder, or eating disorder
  • Inability to lay comfortably in a shallow pool of water
  • Failure to adhere to "pre-float checklist"
  • Breathalyzer test positive for alcohol or a drug-positive urine test
  • Unwillingness to provide consent or complete major aspects of protocol
  • MRI contraindications
  • Unstable medical diagnoses
  • Pregnancy
  • Evidence of inability to comply with study procedures based on experimenter judgement
  • Change in the dose or prescription of a medication within the 6 weeks before enrolling in the study that could affect brain functioning (e.g., anxiolytics, antipsychotics, antidepressants, benzodiazepines, or mood...

The study team makes the final eligibility decision.

Where it's taking place

  • Tulsa, Oklahoma, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 64 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Tulsa, Oklahoma, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.